Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
04/28/2011 | CA2778695A1 Methods and compositions for enhancing polypeptide production |
04/28/2011 | CA2778401A1 Integrin alpha 8-beta 1-specific monoclonal antibody |
04/27/2011 | EP2314711A1 Methods for expression and purification of immunotoxins |
04/27/2011 | EP2314699A1 Medical preparations for the treatment of alpha-galactosidase A deficiency |
04/27/2011 | EP2314696A1 Therapeutic uses of human Interleukin-B50 antagonist. |
04/27/2011 | EP2314695A2 Ligand for receptor activator of NF-kappa B, ligand is member of TNF superfamily |
04/27/2011 | EP2314686A1 Cells producing antibody compositions |
04/27/2011 | EP2314685A1 Cells producing antibody compositions |
04/27/2011 | EP2314676A1 Compositions and methods for the treatment of immune related diseases |
04/27/2011 | EP2314629A1 Recombinant production of mixtures of antibodies |
04/27/2011 | EP2314628A1 Anti-cd27 antibody |
04/27/2011 | EP2314625A1 Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
04/27/2011 | EP2314605A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
04/27/2011 | EP2314317A2 Anti-glypican 3 antibody |
04/27/2011 | EP2313516A1 Compositions and methods for modulating nod-like receptor activity and uses thereof |
04/27/2011 | EP2313515A1 Methods and compositions for targeted single-stranded cleavage and targeted integration |
04/27/2011 | EP2313435A2 Fibroblast growth factor receptor 3 (fgfr3) binding proteins |
04/27/2011 | EP2313434A2 Antibodies that neutralize botulinum neurotoxins |
04/27/2011 | EP1819830B1 Methods for antibody engineering |
04/27/2011 | EP1802750B1 Phytases |
04/27/2011 | EP1539233B1 Super humanized antibodies |
04/27/2011 | EP1532174B1 Anti-igf-i receptor antibody |
04/27/2011 | EP1432446B1 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation |
04/27/2011 | CN1845995B Chimeric antigens for breaking host tolerance to foreign antigens |
04/27/2011 | CN1798836B Methods for preventing gluconoylation of proteins |
04/27/2011 | CN102037134A Method for producing corn gluten hydrolysate and corn gluten hydrolysate using the same |
04/27/2011 | CN102037133A Improved beta thymosin fragments |
04/27/2011 | CN102037132A Methods for enhanced production of bone morphogenetic proteins |
04/27/2011 | CN102037018A Antibody capable of discriminating the change in structure between antibody conjugated with antibody and antibody unconjugated with antibody, and method for production of the antibody |
04/27/2011 | CN102037016A Antibodies to granulocyte-macrophage colony-stimulating factor |
04/27/2011 | CN102036974A Efficient production of heterologous proteins using mannosyl transferase inhibitors |
04/27/2011 | CN102031279A Method for extracting ultralow molecular collagen |
04/27/2011 | CN102031272A Transgenic plants expressing civps or intein modified proteins and related method |
04/27/2011 | CN102031234A Bacillussubtilis for decomposing aflatoxin and active protein secreted by same |
04/27/2011 | CN102030773A Technique for coproducing phytic acid and oligopeptide from defatted rice bran |
04/27/2011 | CN101426907B Cloning and expression of a novel phytase |
04/27/2011 | CN101298596B Method for producing biological enzyme preparation and yeast feed protein |
04/27/2011 | CN101230377B Method for preparing antioxidant collagen peptide by spent of ocean alkaline protease 894 hydrolyzed aquatic products processing |
04/27/2011 | CN101153312B Blood albumen with oxidation resistance liveness and method for preparing the same |
04/26/2011 | US7932431 Genetically modified non-human mammals and cells |
04/26/2011 | US7932375 Kits for detecting rank nucleic acids |
04/26/2011 | US7932371 Tick octopamine receptor nucleic acid molecules |
04/26/2011 | US7932369 Diagnostic test for vitamin B12 |
04/26/2011 | US7932363 Antibody that binds human eosinophil-derived basic protein |
04/26/2011 | US7932362 Antibodies to NRIF3 proteins |
04/26/2011 | US7932360 Recombinant production of mixtures of antibodies |
04/26/2011 | US7932358 Antibodies to JTT-1 protein and cells secreting such antibodies |
04/26/2011 | US7932357 for drug screening compunds that affect inappropriate regulation, development, or physiology of antigen presenting cells |
04/26/2011 | US7932351 Soluble kinase receptor for use in identifying modulators to treat and prevent cell proliferative, respiratory, kidney and liver disorders |
04/26/2011 | US7932229 Peptides for treatment of tumors/cancer |
04/26/2011 | US7932083 Ferrodoxins; hydroxylases; self-replicating plasmid |
04/26/2011 | US7932071 Thermostable ribonuclease H from Archaeoglobus profundus |
04/26/2011 | US7932067 Detection, isolation and uses of renalase (monoamine oxidase C) |
04/26/2011 | US7932066 Unique associated kaposi's sarcoma virus sequences and uses thereof |
04/26/2011 | US7932056 Crustaceans as production systems for therapeutic proteins |
04/26/2011 | US7932055 Soluble heterodimeric CD94/NKG2 receptors fusion proteins |
04/26/2011 | US7932054 Methods of using thermal tolerant avicelase from Acidothermus cellulolyticus |
04/26/2011 | US7932053 Forming triple helical, collagenous protein; directed polypeptide evolution |
04/26/2011 | US7932048 Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody |
04/26/2011 | US7932047 Method for detecting neoplastic disorders in a solubilized body sample |
04/26/2011 | US7931901 T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof |
04/26/2011 | US7931899 Humanized anti-amyloid beta antibodies |
04/26/2011 | US7931898 Methods and compositions for inhibiting binding of IgE to a high affinity receptor |
04/26/2011 | US7931895 Monoclonal antibodies with enhanced ADCC function |
04/26/2011 | CA2509765C Novel peptide-producing enzyme, microbe producing the enzyme and method for dipeptide synthesis using them |
04/26/2011 | CA2420231C Antibodies to human il-1.beta. |
04/26/2011 | CA2309602C Methods and compositions for enhancing immune response and for the production of in vitro mabs |
04/26/2011 | CA2298934C Vectors derived from antibodies for transferring substances into cells |
04/26/2011 | CA2215394C Il-17 receptor |
04/26/2011 | CA2201482C Novel ectoparasite saliva proteins and apparatus to collect such proteins |
04/21/2011 | WO2011047262A2 Dual variable domain immunoglobulins and uses thereof |
04/21/2011 | WO2011047121A1 April antagonists and methods of use |
04/21/2011 | WO2011046855A1 Method for producing proteins in pichia pastoris that lack detectable cross binding activity to antibodies against host cell antigens |
04/21/2011 | WO2011046097A1 Method for manufacturing igg antibodies for a t-cell-independent antigen, genetically modified silkworm that produces igg antibodies for a t-cell-independent antigen, and manufacturing method therefor |
04/21/2011 | WO2011045387A1 Enzyme method of extracting oils and proteins from vegetable matter in an aqueous medium |
04/21/2011 | WO2011045316A1 Protein synthesis via click chemistry |
04/21/2011 | WO2011022472A3 Methods and compositions for the treatment of proliferative and pathogenic diseases |
04/21/2011 | WO2011014659A3 Dual variable domain immunoglobulins and uses thereof |
04/21/2011 | WO2011010792A3 Novel strain of paenibacillus sp. hpl-002 for producing alkaline xylanase, novel xylanase enzyme isolated therefrom, and method for producing same |
04/21/2011 | WO2010132341A3 Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein |
04/21/2011 | WO2007011411A3 N-fragment of edema factor as an antigen for immunization against anthrax |
04/21/2011 | US20110093966 Plant height regulatory gene and uses thereof |
04/21/2011 | US20110093961 Mouse lambda light chain locus |
04/21/2011 | US20110092574 mRNA Cap Analogs |
04/21/2011 | US20110092441 Cell-permeable endostatin recombinant protein, a polynucleotide encoding the same, and an anti-cancer preparation containing the same as an active component |
04/21/2011 | US20110092429 Compositions and methods for producing gamma-carboxylated proteins |
04/21/2011 | US20110092424 Production of glucagon like peptide 2 and analogs |
04/21/2011 | US20110092413 Albumin-Fused Kunitz Domain Peptides |
04/21/2011 | US20110092408 Subtilase Variants |
04/21/2011 | US20110091937 Method of Producing Clostridium Botulinum Toxin Using Media Containing Plant-Derived Components and Flexible Closed Container |
04/21/2011 | US20110091936 Production of proteins in glutamine-free cell culture media |
04/21/2011 | US20110091935 Production of recombinant proteins in synthetic medium |
04/21/2011 | US20110091920 METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX |
04/21/2011 | US20110091901 Vectors and Methods for Screening Cells for High Expression of Protein of Interest (POI) |
04/21/2011 | US20110091896 Method for analysis/identification of antibody gene at one-cell level |
04/21/2011 | US20110091890 Trichoplusia ni cell line and methods of use |
04/21/2011 | US20110091876 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
04/21/2011 | US20110091497 Method For Identifying and Validating Dominant T Helper Cell Epitopes Using An HLA-DM-Assisted Class II Binding Assay |
04/21/2011 | US20110091495 Hcv e2 construct compositions and methods |
04/21/2011 | US20110091494 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |